Health Care Firm Acquires Alliance Life Sciences and Health Strategies Group
CHICAGO – December 5, 2017 – Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has completed two acquisitions to continue building a leading global life sciences’ commercialization services platform. The health care firm has acquired Alliance Life Sciences (Alliance) and Health Strategies Group. Water Street will bring the two companies together with The Access Group, a business it acquired last year, under a global enterprise that will offer life sciences companies a suite of commercialization services to support them with bringing new therapies to market, and gaining and sustaining market access and share.
“We are excited to be at the forefront of helping life sciences firms develop, manage and deliver new outcomes-based therapies that address specific patient populations and diseases,” said Jim Lang, an executive advisor with Water Street who will serve as executive chairman of the newly combined enterprise. “By bringing these two market-leading companies together with The Access Group, we are taking the next step toward building a global leader that will offer life sciences companies an integrated portfolio of solutions to help them bring the right therapies to the right patients at the right value.”
Founded in 1992, Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. Its team of analysts dissects trends and identifies opportunities to help companies optimize their product access and distribution.
Alliance, founded in 2008, specializes in maximizing revenue and optimizing pricing for its customers. The firm offers a broad array of global pricing analytic tools and data, outsourced contract and revenue management services, including business process outsourcing, and digital marketing operational services.
“Together with Health Strategies Group and The Access Group, we will offer our customers a deeper and more extensive portfolio of next-generation solutions that address the entire spectrum of their commercial needs,” said Emmanuel Doe, CEO, Alliance. “As one entity, we will have a greater impact on aligning outcomes among patients, caregivers, physicians and payers for pharmaceutical and medical device products.”
Rod Cavin, managing director, Health Strategies Group, added: “We are thrilled to join forces with Alliance and The Access Group. Our clients are working incredibly fast and hard to bring new and life-changing therapies to market. Building this platform with Water Street enables us to combine our research capabilities with new services that will accelerate getting these therapies to the patients who need them.”
Water Street’s new global enterprise will work with life sciences companies to introduce new therapies and optimize existing therapies to targeted patient populations through the following suite of solutions:
- Strategic and Advisory Consulting Services
- Agency Implementation and Execution
- Research, Data and Analytics Products
- Turnkey Outsourced Operations
Alliance, Health Strategies Group and The Access Group will continue to operate under their current names and leadership teams. The executives of each company will report to the holding company’s board of directors spearheaded by Executive Chairman Jim Lang.
Financial details of the acquisitions are not being disclosed.
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. With more than 15 years of dedicated life sciences experience, its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations. Alliance serves top pharmaceutical manufacturers, mid-market life sciences companies, and multiple medical device and diagnostic firms. For more information, visit www.alscg.com.
About Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment. Recently, Health Strategies Group was ranked the No. 1 market research company that pharmaceutical and biotech executives would recommend for market access insights. For more information, visit healthstrategies.com.
About The Access Group
The Access Group—named a top 100 agency by MM&M five years in a row—offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management—from prelaunch to loss of exclusivity—creating strategic brand solutions that drive demand across multiple stakeholder channels. The Access Group is committed to delivering strategic and tactical solutions that help companies overcome internal and external hurdles in the constantly evolving health care environment. For more information, visit theaccessgp.com.
About Water Street
Water Street is a strategic investor focused exclusively on health care. The firm has a strong record of building market-leading companies across key growth sectors in health care. It has worked with some of the world’s leading health care companies on its investments including Johnson & Johnson, Medtronic, Smith & Nephew and Walgreen Co. Water Street’s team is comprised of industry executives and investment professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago. For more information about Water Street, visit waterstreet.com.